HRT Financial’s Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 PNTM.WS Stock Holding History

HRT Financial's PNTM.WS Position: Q2 2023 in Review

HRT Financial sold out of Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (PNTM.WS) in Q2 2023, closing a stake of 33,318 shares — an estimated $5K sold.

HRT Financial first reported a position in PNTM.WS in Q1 2023 and held it in 1 quarter. The position peaked at $5K in Q1 2023. 0 funds tracked by Wall St. Rank hold PNTM.WS as of Q2 2023.

• HRT Financial reported no remaining Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2023 after selling out during the quarter.
• HRT Financial sold 33,318 Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2023, an estimated $5K.
• HRT Financial first reported a position in Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2023 and held it in 1 quarter.
• HRT Financial's Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $5K in Q1 2023.
• 0 funds tracked by Wall St. Rank held Pontem Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2023.

Based on HRT Financial's 13F filing for Q2 2023, filed 11 Aug 2023.